BIRC5 and cancer: Analysis of Survivin_oHSV replication showed that the ICP4 conditioning by Survivin/BIRC5 promoter mediated up to 3 orders of magnitude of selectivity for cancer cells as compared to non-tumour MRC5 fibroblasts.